Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Patrick Jason Meyenburg > Profile

Patrick Jason Meyenburg

Affiliations

  • Chief Executive Officer at Gemini Therapeutics Inc. (GMTX), 2022-01-05
  • Chief Commercial Officer at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GMTX $9.46 13,000 $122,929.30 13,000 2021-05-14 Filing
SCMP $12.13 4,000 $48,500.00 30,228 2017-09-06 Filing